Evidence map›Paper›PMID 40104654›Full record

ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2024

Tomasz Kolenda, Joanna Kozłowska-Masłoń, Patrycja Mantaj, Nina Grzejda, Kacper Kamiński, Maria Dziuba, Małgorzata Czarnecka, Aleksandra Leszczyńska, Paulina Poter, Kacper Guglas and 10 more

Abstract read
In one paragraph

Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Biomedicines · 2026
    Article
  2. lncRNABiomedicines · 2025
    Article
  3. Pseudogenes in the carcinogenesis: epithelial-to-mesenchymal transition process and cancer initiating cells.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Review
  4. Transcriptome-based model for predicting radiotherapy response in HNSCC patients.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Tomasz KolendaMicrobiology Laboratorium, Greater Poland Cancer Centre, Poznan, Poland.
Joanna Kozłowska-MasłońLaboratory of Cancer Genetics Poznan, Greater Poland Cancer Centre, Poznan, Poland.
Patrycja MantajDepartment of Radiation Protection, Greater Poland Cancer Centre, Poznan, Poland.
Nina GrzejdaLaboratory of Cancer Genetics Poznan, Greater Poland Cancer Centre, Poznan, Poland.
Kacper KamińskiChair of Medical Biotechnology, Department of Cancer Immunology, Poznan University of Medical Sciences, Poznan, Poland.
Maria DziubaChair of Medical Biotechnology, Department of Cancer Immunology, Poznan University of Medical Sciences, Poznan, Poland.
Małgorzata CzarneckaChair of Medical Biotechnology, Department of Cancer Immunology, Poznan University of Medical Sciences, Poznan, Poland.
Aleksandra LeszczyńskaChair of Medical Biotechnology, Department of Cancer Immunology, Poznan University of Medical Sciences, Poznan, Poland.
Paulina PoterDepartment of Clinical Pathology, Poznan University of Medical Sciences and Greater Poland Cancer Centre, Poznan, Poland.
Kacper GuglasLaboratory of Cancer Genetics Poznan, Greater Poland Cancer Centre, Poznan, Poland.
Klaudia DudekLaboratory of Cancer Genetics Poznan, Greater Poland Cancer Centre, Poznan, Poland.
Katarzyna RegulskaResearch and Implementation Unit, Greater Poland Cancer Centre, Poznan, Poland.
Paulina GieremekPharmacy, Greater Poland Cancer Centre, Poznan, Poland.
Beata StaniszDepartament of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Poznan, Poland.
Anna Florczak-SubstykChair of Medical Biotechnology, Department of Cancer Immunology, Poznan University of Medical Sciences, Poznan, Poland.
Marlena Janiczek-PolewskaDepartment of Clinical Oncology, Greater Poland Cancer Centre, Poznan, Poland.
Urszula KazimierczakChair of Medical Biotechnology, Department of Cancer Immunology, Poznan University of Medical Sciences, Poznan, Poland.
Katarzyna LamperskaResearch and Implementation Unit, Greater Poland Cancer Centre, Poznan, Poland.
Zefiryn CybulskiMicrobiology Laboratorium, Greater Poland Cancer Centre, Poznan, Poland.
Anna TeresiakResearch and Implementation Unit, Greater Poland Cancer Centre, Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pseudogenes are epigenetic elements whose function is mostly unknown in cancer including head and neck cancers (HNSCCs). In our study we analyzed selected three pseudogenes, aurora kinase A pseudogene 1 ( Materials and methods: Based on The Cancer Genome Atlas (TCGA) data we checked potential association of pseudogenes with pathological and clinical features, survival, cellular phenotype and involvement in pathways and cellular processes, and association with patients' response to radiotherapy. Results: Only Conclusions:

Indexed as

biomarkerHNSCCHPVlncRNAnon-coding RNAoncogenepseudogenesuppressorTCGA

Identifiers

PMID40104654
PMCPMC11912886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.